In a report released today, Stacy Ku from TD Cowen maintained a Buy rating on Supernus Pharmaceuticals (SUPN – Research Report), with a price ...

NEW YORK, NY / ACCESS Newswire / April 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Supernus Pharmaceuticals, Inc. ("Supernus Pharmaceuticals ...

Dublin, April 14, 2025 (GLOBE NEWSWIRE) -- The "Botulinum Toxin Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering. The Botulinum Toxins Market, valued at ...

Supernus Pharma, and Deerfield Cures. By integrating Elion into Renovaro’s workflow, the combined business aims to streamline the translation of biomarker insights into accelerated discovery timelines ...

Significant reduction also seen in change from baseline in daily OFF times vs placebo. HealthDay News — For patients with Parkinson disease with motor fluctuations, the oral once-daily ...

Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment Quarterly earnings results are a good time to check in on a company’s progress, especially compared to ...

Please provide your email address to receive an email when new articles are posted on . An AI-powered wristband was more effective than a sham device in improving essential tremor. It could be ...

COSTA MESA, Calif., April 7, 2025 /PRNewswire/ -- A major international study, published this week in JAMA Psychiatry, has identified a powerful new brain-based biomarker for Major Depressive Disorder ...

NEW YORK, NY / ACCESS Newswire / April 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Supernus Pharmaceuticals, Inc. ("Supernus Pharmaceuticals ...

Prudential Financial Inc.’s holdings in Supernus Pharmaceuticals were worth $2,374,000 as of its most recent filing with the Securities and Exchange Commission (SEC).